An interview with Tim Guilliams, Co-founder and CEO of Healx, aiming to find new therapeutic solutions to cure patients with rare diseases. Tim tells how he is utilising machine learning to bring his therapies to trial. Healx was previously on the Accelerate Cambridge programme run by the Cambridge Judge Entrepreneurship Centre. (subs)
Read the full article [telegraph-co-uk]
Comments